G1 Therapeutics Insider Trades

GTHX

Track insider trading activity from G1 Therapeutics executives and directors. See which insiders are buying and selling GTHX stock.

Trades Last 12 Months

GTHX Price

All Insider Trades for G1 Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Avagliano Mark Chief Business Officer
Holding Value $186k 26,035 shares
Last Trade
Sep 18, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.63M 367,110 shares
$7.16
$7.16
Bailey John E. (Jack) Jr. President And CEO
Holding Value $0 0 shares
Last Trade
Sep 18, 2024 Sale (Tender)Reported as Tender on SEC Form 4.
$1.41M 196,287 shares
$7.16
$7.16
Holding Value $0 0 shares
Last Trade
Sep 18, 2024 Sale (Tender)Reported as Tender on SEC Form 4.
$114k 15,889 shares
$7.16
$7.16
Lee Jacks Director
Holding Value $71.6k 10,000 shares
Last Trade
Sep 18, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$931k 130,000 shares
$7.16
$7.16
Malik Rajesh Chief Medical Officer
Holding Value $1.27M 177,212 shares
Last Trade
Sep 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$128k 17,900 shares
$7.16
$7.16
Muir Glenn P Director
Holding Value $0 0 shares
Last Trade
Sep 18, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$215k 30,000 shares
$7.16
$7.16
Murdock Terry L Chief Operating Officer
Holding Value $0 0 shares
Last Trade
Sep 18, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$533k 74,500 shares
$7.16
$7.16
Holding Value $103k 14,389 shares
Last Trade
Sep 18, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$788k 110,000 shares
$7.16
$7.16
Perry Andrew Chief Commercial Officer
Holding Value $102k 14,232 shares
Last Trade
Sep 18, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.53M 213,632 shares
$7.16
$7.16
Secor Alicia Director
Holding Value $71.6k 10,000 shares
Last Trade
Sep 18, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$358k 50,000 shares
$7.15
$7.16
Sharpless Norman Director
Holding Value $0 0 shares
Last Trade
Sep 18, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$573k 80,000 shares
$7.16
$7.16
Thomas Monica R. Chief Legal & People Officer
Holding Value $47.8k 6,674 shares
Last Trade
Sep 18, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.46M 344,026 shares
$7.16
$7.16
Umstead John W. V Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Sep 18, 2024 Sale (Tender)Reported as Tender on SEC Form 4.
$138k 19,331 shares
$7.16
$7.16
Velleca Mark A. Director
Holding Value $1.73M 242,286 shares
Last Trade
Aug 08, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$122k 60,000 shares
$2.03
$7.16
Umstead John V. Chief Financial Officer
Holding Value $672k 93,886 shares
Last Trade
May 10, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$102k 35,000 shares
$2.92
$7.16
Hanson James S. Director, General Counsel
Holding Value $294k 41,087 shares
Last Trade
Jan 05, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.94k 729 shares
$5.41
$7.16
Moses Jennifer K. Director, CFO
Holding Value $414k 57,820 shares
Last Trade
Jan 05, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.94k 729 shares
$5.41
$7.16
Deese Willie A Director
Holding Value $215k 30,000 shares
Last Trade
Jun 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$159k 30,000 shares
$5.30
$7.16
Rudnick Seth Director
Holding Value $84.9k 11,859 shares
Last Trade
Jun 29, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$226k 10,000 shares
$22.61
$7.16
Schwalm Cynthia Director
Holding Value $140k 19,620 shares
Last Trade
Jun 17, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$431k 19,620 shares
$21.97
$7.16

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up